Biohaven's troriluzole candidate for spinocerebellar ataxia (SCA) has been turned down by the FDA, causing shares in the company to lose more than 40% of their value in pre-market trading. The news is ...
Dyspraxia is a neurological disorder that makes it hard to plan and process motor tasks, often affecting coordination. It is usually diagnosed in early childhood, but symptoms can continue into ...